Recently, Zacks.com users have been paying close attention to Toyota Motor (TM). This makes it worthwhile to examine what the stock has in store.

Zacks.com users have recently been watching Enphase Energy (ENPH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks.com users have recently been watching Paypal (PYPL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Recently, Zacks.com users have been paying close attention to Affirm Holdings (AFRM). This makes it worthwhile to examine what the stock has in store.

NextEra (NEE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

A new presidential administration and an inflection point for the Federal Reserve are adding a high degree of uncertainty to the market. That could bring forth heightened volatility.

e.l.f. Beauty (ELF) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Recently, Zacks.com users have been paying close attention to Disney (DIS). This makes it worthwhile to examine what the stock has in store.

Advanced Micro (AMD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Marathon Petroleum (MPC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Skyworks Solutions, Inc. ("Skyworks" or "the Company") (NASDAQ:SWKS). Investors who purchased Skyworks securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SWKS.

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Huntington Ingalls Industries, Inc. ("Huntington Ingalls" or "the Company") (NYSE:HII). Investors who purchased Huntington Ingalls securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HII.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allarity Therapeutics, Inc. ("Allarity" or "the Company") (NASDAQ:ALLR). Investors who purchased Allarity securities prior to May 17, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ALLR.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FMC Corporation ("FMC" or "the Company") (NYSE:FMC). Investors who purchased FMC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FMC.

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dominion Energy, Inc. ("Dominion" or "the Company") (NYSE:D). Investors who purchased Dominion securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/D.

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lamb Weston Holdings, Inc. ("Lamb Weston" or "the Company") (NYSE:LW). Investors who purchased Lamb Weston securities prior to July 25, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LW.

MILWAUKEE , Feb. 10, 2025 /PRNewswire/ -- Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, has been named a top thermal management provider for data centers by ABI Research. The recognition highlights Johnson Controls' excellence in innovation and implementation, driven by its comprehensive product portfolio, global presence, and customer-centric approach to the data center thermal management industry.

First Cohort B patient received 4 doses (approx. 819 million Gamma Delta T-cells) Cohort B recruitment continues at multiple clinical sites across the United Kingdom EDINBURGH, Scotland , Feb. 10, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the first Cohort B patient in the ACHIEVE Phase 2B UK clinical trial, evaluating TCB008 in Acute Myeloid Leukemia, has completed the full dosing regiment.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Construction Partners, Inc. ("Construction Partners" or "the Company") (NASDAQ:ROAD). Investors who purchased Construction Partners securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ROAD.

Tesla's stock continues to pullback, as the souring of public opinion toward CEO Elon Musk fuels worries of lower sales.